CVR: 39126729
DKK 1,169,131
Gross profit
Net result: DKK -31,204,765
River Stone Biotech Inc.
CVR · view ownership and management
Director registered: Jørgen Hansen
CVR · 21/12/2018
View the full event history
River Stone Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jørgen Hansen. The company is owned by River Stone Biotech Inc.. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 1,169,131 and a net result of DKK -31,204,765 compared with DKK -44,572,973 the year before. Equity in the 2025 report amounted to DKK 7,827,761.
Source: annual report 2025, Danish Business Authority
The financial health of River Stone Biotech ApS appears to be concerning, with consistent losses over the past five years, culminating in a profit of -31,204,765 DKK in 2025. Gross profit has shown a declining trend from 7,577,381 DKK in 2021 to 1,169,131 DKK in 2025, indicating challenges in maintaining revenue generation despite initial growth. The company's equity has also decreased significantly, from 14,828,301 DKK in 2023 to 7,827,761 DKK in 2025, raising concerns about its financial stability and ability to attract further investment. Positioned within the research and experimental development sector, the company faces significant hurdles in achieving profitability and sustaining operations amidst increasing losses.
AI-generated summary · Generated 16/08/2026
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.2 mio. | -31.2 mio. | 11.8 mio. | 7.8 mio. | 25 | |
| 202401/01/2024 – 31/12/2024 | 3.2 mio. | -44.6 mio. | 15.4 mio. | 10.6 mio. | 23 | |
| 202301/01/2023 – 31/12/2023 | 3.4 mio. | -72.4 mio. | 22.4 mio. | 14.8 mio. | 22 | |
| 202201/01/2022 – 31/12/2022 | 7.3 mio. | -52 mio. | 24.9 mio. | 10.7 mio. | 22 | |
| 202101/01/2021 – 31/12/2021 | 7.6 mio. | -18.8 mio. | 18.6 mio. | -9.8 mio. | 18 | |
| 202001/01/2020 – 31/12/2020 | 2.5 mio. | -16.1 mio. | 13.1 mio. | 8.9 mio. | 15 | |
| 201901/01/2019 – 31/12/2019 | 692 t. | -14.3 mio. | 12.6 mio. | 10.1 mio. | 13 | |
| 201830/11/2017 – 31/12/2018 | - | -11.1 mio. | 8.7 mio. | -11.1 mio. | 11 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningRiver Stone Biotech ApS was founded on 30 November 2017.
River Stone Biotech ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
River Stone Biotech ApS had 15 employees in 2018 according to the Danish CVR register.
River Stone Biotech ApS is owned by River Stone Biotech Inc..
In 2025, River Stone Biotech ApS reported a gross profit of DKK 1,169,131.
The management of River Stone Biotech ApS consists of Jørgen Hansen.
Claim this page to add your logo and social links. Free to get started.
River Stone Biotech ApS has published its annual report for 2025. Gross profit came to DKK 1,169,131, and the net result was DKK -31,204,765.
River Stone Biotech ApS has published its annual report for 2024. Gross profit came to DKK 3,191,557, and the net result was DKK -44,572,973.
River Stone Biotech ApS has published its annual report for 2023. Gross profit came to DKK 3,445,469, and the net result was DKK -72,439,968.
As of May 21, 2024, Ri Statsautoriseret Revisionspartnerselskab has been appointed auditor of River Stone Biotech ApS.
As of May 20, 2024, Ri Magnoliavej 12 ApS has stepped down as auditor of River Stone Biotech ApS.
River Stone Biotech ApS has published its annual report for 2022. Gross profit came to DKK 7,307,696, and the net result was DKK -52,037,040.
River Stone Biotech ApS has published its annual report for 2021. Gross profit came to DKK 7,577,381, and the net result was DKK -18,792,979.
River Stone Biotech ApS has published its annual report for 2020. Gross profit came to DKK 2,476,810, and the net result was DKK -16,064,190.
River Stone Biotech ApS has published its annual report for 2019. Gross profit came to DKK 691,841, and the net result was DKK -14,329,089.
River Stone Biotech ApS has published its annual report for 2018. The net result was DKK -11,103,388.
As of February 6, 2019, Ri Magnoliavej 12 ApS has been appointed auditor of River Stone Biotech ApS.
As of February 6, 2019, EY Godkendt Revisionspartnerselskab has stepped down as auditor of River Stone Biotech ApS.
As of December 21, 2018, Jørgen Hansen has joined the board of directors of River Stone Biotech ApS.
As of December 21, 2018, Paul D. Goldenheim has joined the board of directors of River Stone Biotech ApS.
As of December 21, 2018, Jørgen Hansen is registered as adm. dir. of River Stone Biotech ApS.
As of December 21, 2018, Paul D. Goldenheim has stepped down as director of River Stone Biotech ApS.
As of November 30, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of River Stone Biotech ApS.
As of November 30, 2017, Paul D. Goldenheim is registered as director of River Stone Biotech ApS.
As of November 30, 2017, is registered as an owner of River Stone Biotech ApS with an ownership share of 100%.
River Stone Biotech ApS was founded on November 30, 2017.
Companies in the same industry and area
CVR 39330784
CVR 26333210
CVR 26392861
CVR 41366044
CVR 27701396
